Capricor Therapeutics
CAPR
#6250
Rank
โ‚ฌ0.59 B
Marketcap
16,88ย โ‚ฌ
Share price
-0.97%
Change (1 day)
528.56%
Change (1 year)

Revenue for Capricor Therapeutics (CAPR)

Revenue in 2024 (TTM): โ‚ฌ25.02 Million

According to Capricor Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ25.03 Million. In 2023 the company made a revenue of โ‚ฌ22.77 Million an increase over the revenue in the year 2022 that were of โ‚ฌ2.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Capricor Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ25.02 M9.88%
2023 โ‚ฌ22.77 M857.54%
2022 โ‚ฌ2.37 M999.96%
2021 โ‚ฌ0.21 M-14.27%
2020 โ‚ฌ0.25 M-71.88%
2019 โ‚ฌ0.89 M-38.59%
2018 โ‚ฌ1.46 M-19.98%
2017 โ‚ฌ1.82 M-39.8%
2016 โ‚ฌ3.03 M-12.18%
2015 โ‚ฌ3.45 M0.8%
2014 โ‚ฌ3.42 M
2013 N/A-100%
2012 โ‚ฌ0.14 M-85.83%
2011 โ‚ฌ1.04 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ2.88 M-88.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.14 M-83.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ79.83 B 318,754.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.95 B 7,705.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.65 M-69.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.14 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA